Kerry A. Wentworth
2013
In 2013, Kerry A. Wentworth earned a total compensation of $567.2K as Vice President, Clinical, Regulatory and Quality at Agenus, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,362 |
|---|---|
| Option Awards | $142,367 |
| Salary | $267,120 |
| Other | $9,356 |
| Total | $567,205 |
Wentworth received $267.1K in salary, accounting for 47% of the total pay in 2013.
Wentworth also received $148.4K in non-equity incentive plan, $142.4K in option awards and $9.4K in other compensation.
Rankings
In 2013, Kerry A. Wentworth's compensation ranked 8,896th out of 12,286 executives tracked by ExecPay. In other words, Wentworth earned more than 27.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,896 out of 12,286 | 28th |
Division Manufacturing | 3,242 out of 4,612 | 30th |
Major group Chemicals And Allied Products | 1,035 out of 1,462 | 29th |
Industry group Drugs | 791 out of 1,156 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 128 out of 196 | 35th |
Source: SEC filing on March 10, 2014.
Wentworth's colleagues
We found four more compensation records of executives who worked with Kerry A. Wentworth at Agenus in 2013.